Welcome!

News Feed Item

Tremor Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Tremor Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312347/Tremor-Global-Clinical-Trials-Review-H2-2014.html

Tremor Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Tremor Global Clinical Trials Review, H2, 2014" provides data on the Tremor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tremor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tremor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Tremor 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Tremor to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Tremor to Central Nervous System Clinical Trials 16
Clinical Trials by Phase 17

In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Tremor 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Tremor Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Veloxis Pharmaceuticals A/S 27
Clinical Trial Overview of Veloxis Pharmaceuticals A/S 27
Clinical Trial Overview of Top Institutes / Government 28
University of Alabama at Birmingham 28
Clinical Trial Overview of University of Alabama at Birmingham 28
National Institute of Neurological Disorders and Stroke 29
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 29
Boston Children's Hospital 30
Clinical Trial Overview of Boston Children's Hospital 30
Ohio State University 31

Clinical Trial Overview of Ohio State University 31
Emory University 32
Clinical Trial Overview of Emory University 32
Mayo Clinic 33
Clinical Trial Overview of Mayo Clinic 33
Syracuse University 34
Clinical Trial Overview of Syracuse University 34
Yazd Medical University 35
Clinical Trial Overview of Yazd Medical University 35
Mount Sinai Hospital 36
Clinical Trial Overview of Mount Sinai Hospital 36
University of California, Davis 37
Clinical Trial Overview of University of California, Davis 37
Five Key Clinical Profiles 38
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 61

List of Tables
Tremor Therapeutics, Global, Clinical Trials by Region, 2014* 6
Tremor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tremor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tremor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Tremor Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Tremor Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Tremor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Tremor to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tremor Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tremor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tremor to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tremor Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Tremor Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Tremor Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Tremor Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Tremor Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Tremor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Tremor Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Tremor Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Tremor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Tremor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Veloxis Pharmaceuticals A/S, 2014* 27
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 28
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 29
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014* 30

Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University, 2014* 31
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 32
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 33
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Syracuse University, 2014* 34
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Yazd Medical University, 2014* 35
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2014* 36
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014* 37

List of Figures
Tremor Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Tremor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tremor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tremor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9

Proportion of Tremor to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tremor Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tremor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tremor to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tremor Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Tremor Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Tremor Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Tremor Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Tremor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Tremor Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Tremor Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Tremor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 60

Read the full report:
Tremor Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312347/Tremor-Global-Clinical-Trials-Review-H2-

2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com  
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life sett...
Video experiences should be unique and exciting! But that doesn’t mean you need to patch all the pieces yourself. Users demand rich and engaging experiences and new ways to connect with you. But creating robust video applications at scale can be complicated, time-consuming and expensive. In his session at @ThingsExpo, Zohar Babin, Vice President of Platform, Ecosystem and Community at Kaltura, will discuss how VPaaS enables you to move fast, creating scalable video experiences that reach your ...
SYS-CON Events announced today that Bsquare has been named “Silver Sponsor” of SYS-CON's @ThingsExpo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. For more than two decades, Bsquare has helped its customers extract business value from a broad array of physical assets by making them intelligent, connecting them, and using the data they generate to optimize business processes.
In his session at @ThingsExpo, Kausik Sridharabalan, founder and CTO of Pulzze Systems, Inc., will focus on key challenges in building an Internet of Things solution infrastructure. He will shed light on efficient ways of defining interactions within IoT solutions, leading to cost and time reduction. He will also introduce ways to handle data and how one can develop IoT solutions that are lean, flexible and configurable, thus making IoT infrastructure agile and scalable.
Businesses are struggling to manage the information flow and interactions between all of these new devices and things jumping on their network, and the apps and IT systems they control. The data businesses gather is only helpful if they can do something with it. In his session at @ThingsExpo, Chris Witeck, Principal Technology Strategist at Citrix, will discuss how different the impact of IoT will be for large businesses, expanding how IoT will allow large organizations to make their legacy ap...
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). Download Slide Deck: ▸ Here In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discusse...
In this strange new world where more and more power is drawn from business technology, companies are effectively straddling two paths on the road to innovation and transformation into digital enterprises. The first path is the heritage trail – with “legacy” technology forming the background. Here, extant technologies are transformed by core IT teams to provide more API-driven approaches. Legacy systems can restrict companies that are transitioning into digital enterprises. To truly become a lea...
There are several IoTs: the Industrial Internet, Consumer Wearables, Wearables and Healthcare, Supply Chains, and the movement toward Smart Grids, Cities, Regions, and Nations. There are competing communications standards every step of the way, a bewildering array of sensors and devices, and an entire world of competing data analytics platforms. To some this appears to be chaos. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, Bradley Holt, Developer Advocate a...
24Notion is full-service global creative digital marketing, technology and lifestyle agency that combines strategic ideas with customized tactical execution. With a broad understand of the art of traditional marketing, new media, communications and social influence, 24Notion uniquely understands how to connect your brand strategy with the right consumer. 24Notion ranked #12 on Corporate Social Responsibility - Book of List.
Just over a week ago I received a long and loud sustained applause for a presentation I delivered at this year’s Cloud Expo in Santa Clara. I was extremely pleased with the turnout and had some very good conversations with many of the attendees. Over the next few days I had many more meaningful conversations and was not only happy with the results but also learned a few new things. Here is everything I learned in those three days distilled into three short points.
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Major trends and emerging technologies – from virtual reality and IoT, to Big Data and algorithms – are helping organizations innovate in the digital era. However, to create real business value, IT must think beyond the ‘what’ of digital transformation to the ‘how’ to harness emerging trends, innovation and disruption. Architecture is the key that underpins and ties all these efforts together. In the digital age, it’s important to invest in architecture, extend the enterprise footprint to the cl...
The vision of a connected smart home is becoming reality with the application of integrated wireless technologies in devices and appliances. The use of standardized and TCP/IP networked wireless technologies in line-powered and battery operated sensors and controls has led to the adoption of radios in the 2.4GHz band, including Wi-Fi, BT/BLE and 802.15.4 applied ZigBee and Thread. This is driving the need for robust wireless coexistence for multiple radios to ensure throughput performance and th...
DevOps at Cloud Expo, taking place Nov 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long dev...
If you had a chance to enter on the ground level of the largest e-commerce market in the world – would you? China is the world’s most populated country with the second largest economy and the world’s fastest growing market. It is estimated that by 2018 the Chinese market will be reaching over $30 billion in gaming revenue alone. Admittedly for a foreign company, doing business in China can be challenging. Often changing laws, administrative regulations and the often inscrutable Chinese Interne...